Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease

Nutrition

Volumn 23, Issue 9, 2007, Pages 625-633

  Earnest, Conrad P ^a   Mikus, Catherine R ^a   Lemieux, Isabelle ^b   Arsenault, Benoit J ^b,c   Church, Timothy S ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cholesterol; Lipid dietary supplement; Phytosterol ester

Indexed keywords

ESTER DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; PLACEBO;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INTERVENTION STUDY; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PHYTOSTEROLS;

EID: 34547700784     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.06.003     Document Type: Article

References (61)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
2. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 (1998) 1569-1575
3. MacLennan A.H., Wilson D.H., and Taylor A.W. The escalating cost and prevalence of alternative medicine. Prev Med 35 (2002) 166-173
4. Gylling H., and Miettinen T.A. Cholesterol reduction by different plant stanol mixtures and with variable fat intake. Metabolism 48 (1999) 575-580
5. Hallikainen M.A., Sarkkinen E.S., Gylling H., Erkkila A.T., and Uusitupa M.I. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 54 (2000) 715-725
6. Jones P.J. Cholesterol-lowering action of plant sterols. Curr Atheroscler Rep 1 (1999) 230-235
7. Lottenberg A.M., Nunes V.S., Nakandakare E.R., Neves M., Bernik M., Lagrost L., et al. The human cholesteryl ester transfer protein I405V polymorphism is associated with plasma cholesterol concentration and its reduction by dietary phytosterol esters. J Nutr 133 (2003) 1800-1805
8. Newby L.K., LaPointe N.M., Chen A.Y., Kramer J.M., Hammill B.G., DeLong E.R., et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 113 (2006) 203-212
9. Plat J., and Mensink R.P. Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects. Atherosclerosis 148 (2000) 101-112
10. Dietary supplement may help lower elevated cholesterol. Mayo Clin Health Lett 20 8 (2002) 4
11. Miettinen T.A., and Gylling H. Effect of statins on noncholesterol sterol levels: implications for use of plant stanols and sterols. Am J Cardiol 96 suppl 1A (2005) 40D-46D
12. Food labeling: health claims; plant sterol/stanol esters and coronary heart disease. Interim final rule; notice of extension of period for issuance of final rule. Fed Regist 66 (2001) 30311-30313
13. Simons L.A. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia. Am J Cardiol 90 (2002) 737-740
14. Gylling H., Radhakrishnan R., and Miettinen T.A. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol. Circulation 96 (1997) 4226-4231
15. Miettinen T.A., Puska P., Gylling H., Vanhanen H., and Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 333 (1995) 1308-1312
16. Vanhanen H.T., Blomqvist S., Ehnholm C., Hyvonen M., Jauhiainen M., Torstila I., et al. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res 34 (1993) 1535-1544
17. Vanhanen H.T., Kajander J., Lehtovirta H., and Miettinen T.A. Serum levels, absorption efficiency, faecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolaemic subjects. Clin Sci (Lond) 87 (1994) 61-67
18. Davidson M.H., Maki K.C., Umporowicz D.M., Ingram K.A., Dicklin M.R., Schaefer E., et al. Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women. J Am Coll Nutr 20 (2001) 307-319
19. De Graaf J., De Sauvage Nolting P.R., Van Dam M., Belsey E.M., Kastelein J.J., Haydn Pritchard P., et al. Consumption of tall oil-derived phytosterols in a chocolate matrix significantly decreases plasma total and low-density lipoprotein-cholesterol levels. Br J Nutr 88 (2002) 479-488
20. Matvienko O.A., Lewis D.S., Swanson M., Arndt B., Rainwater D.L., Stewart J., et al. A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men. Am J Clin Nutr 76 (2002) 57-64
21. Mensink R.P., Ebbing S., Lindhout M., Plat J., and van Heugten M.M. Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis 160 (2002) 205-213
22. Homma Y., Ikeda I., Ishikawa T., Tateno M., Sugano M., and Nakamura H. Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial. Nutrition 19 (2003) 369-374
23. Lee Y.M., Haastert B., Scherbaum W., and Hauner H. A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus-a randomized controlled trial under free-living conditions. Eur J Nutr 42 (2003) 111-117
24. Maki K.C., Davidson M.H., Umporowicz D.M., Schaefer E.J., Dicklin M.R., Ingram K.A., et al. Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr 74 (2001) 33-43
25. Devaraj S., Jialal I., and Vega-Lopez S. Plant sterol-fortified orange juice effectively lowers cholesterol levels in mildly hypercholesterolemic healthy individuals. Arterioscler Thromb Vasc Biol 24 (2004) e25-e28
26. Spilburg C.A., Goldberg A.C., McGill J.B., Stenson W.F., Racette S.B., Bateman J., et al. Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol. J Am Diet Assoc 103 (2003) 577-581
27. Goldberg A.C., Ostlund Jr. R.E., Bateman J.H., Schimmoeller L., McPherson T.B., and Spilburg C.A. Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs. Am J Cardiol 97 (2006) 376-379
28. McPherson T.B., Ostlund R.E., Goldberg A.C., Bateman J.H., Schimmoeller L., and Spilburg C.A. Phytostanol tablets reduce human LDL-cholesterol. J Pharm Pharmacol 57 (2005) 889-896
29. Muntner P., He J., Roccella E.J., and Whelton P.K. The impact of JNC-VI guidelines on treatment recommendations in the US population. Hypertension 39 (2002) 897-902
30. Earnest C.P., Wood K.A., and Church T.S. Complex multivitamin supplementation improves homocysteine and resistance to LDL-C oxidation. J Am Coll Nutr 22 (2003) 400-407
31. Earnest C., Cooper K.H., Marks A., and Mitchell T.L. Efficacy of a complex multivitamin supplement. Nutrition 18 (2002) 738-742
32. Earnest C.P., Jordan A.N., Safir M., Weaver E., and Church T.S. Cholesterol-lowering effects of bovine serum immunoglobulin in participants with mild hypercholesterolemia. Am J Clin Nutr 81 (2005) 792-798
33. Borrud L.G., Pillow P.C., Allen P.K., McPherson R.S., Nichaman M.Z., and Newell G.R. Food group contributions to nutrient intake in whites, blacks, and Mexican Americans in Texas. J Am Diet Assoc 89 (1989) 1061-1069
34. Cleveland L.E., Cook D.A., Krebs-Smith S.M., and Friday J. Method for assessing food intakes in terms of servings based on food guidance. Am J Clin Nutr 65 suppl (1997) 1254S-1263S
35. McPherson R.S., Kohl III H.W., Garcia G., Nichaman M.Z., and Hanis C.L. Food-frequency questionnaire validation among Mexican-Americans: Starr County, Texas. Ann Epidemiol 5 (1995) 378-385
36. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
37. St-Pierre A.C., Ruel I.L., Cantin B., Dagenais G.R., Bernard P.M., Despres J.P., et al. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104 (2001) 2295-2299
38. Rainwater D.L., Mitchell B.D., Comuzzie A.G., and Haffner S.M. Relationship of low-density lipoprotein particle size and measures of adiposity. Int J Obes Relat Metab Disord 23 (1999) 180-189
39. Cheng M.L., Kammerer C.M., Lowe W.F., Dyke B., and VandeBerg J.L. Method for quantitating cholesterol in subfractions of serum lipoproteins separated by gradient gel electrophoresis. Biochem Genet 26 (1988) 657-681
40. Carmena R., Duriez P., and Fruchart J.C. Atherogenic lipoprotein particles in atherosclerosis. Circulation 109 suppl 1 (2004) III2-III7
41. Choi B.G., Vilahur G., Yadegar D., Viles-Gonzalez J.F., and Badimon J.J. The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular diseases. Curr Mol Med 6 (2006) 571-587
42. Moruisi K.G., Oosthuizen W., and Opperman A.M. Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J Am Coll Nutr 25 (2006) 41-48
43. Jenkins D.J., Kendall C.W., Marchie A., Faulkner D.A., Wong J.M., de Souza R., et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 81 (2005) 380-387
44. Food and Drug Administration Department of Health and Human Services. Subchapter B-food for human consumption. Specific requirements for health claims, sec. 101.83 health claims: plant sterol/stanol esters and risk of coronary heart disease Code of Federal Regulations 2006; volume 2; revised as of April 1, 2006 (21): part 101: food labeling.
45. Clifton P.M., Noakes M., Sullivan D., Erichsen N., Ross D., Annison G., et al. Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal. Eur J Clin Nutr 58 (2004) 503-509
46. Jones P.J., Vanstone C.A., Raeini-Sarjaz M., and St-Onge M.P. Phytosterols in low- and nonfat beverages as part of a controlled diet fail to lower plasma lipid levels. J Lipid Res 44 (2003) 1713-1719
47. Lemieux I., Pascot A., Couillard C., Lamarche B., Tchernof A., Almeras N., et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 102 (2000) 179-184
48. Tchernof A., Lamarche B., Prud'Homme D., Nadeau A., Moorjani S., Labrie F., et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19 (1996) 629-637
49. St-Pierre A.C., Cantin B., Dagenais G.R., Mauriege P., Bernard P.M., Despres J.P., et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25 (2005) 553-559
50. Lamarche B., Desroches S., Jenkins D.J., Kendall C.W., Marchie A., Faulkner D., et al. Combined effects of a dietary portfolio of plant sterols, vegetable protein, viscous fibre and almonds on LDL particle size. Br J Nutr 92 (2004) 657-663
51. Piironen V., Lindsay D., Mietten T., Toivo J., and Lampi A. Plant sterols: biosynthesis, biological function and their importance to human nutrition. J Sci Food Agric 80 (2000) 939-966
52. Varady K.A., St-Pierre A.C., Lamarche B., and Jones P.J. Effect of plant sterols and endurance training on LDL particle size and distribution in previously sedentary hypercholesterolemic adults. Eur J Clin Nutr 59 (2005) 518-525
53. Charest A., Vanstone C., St-Onge M.P., Parson W., Jones P.J., and Lamarche B. Phytosterols in nonfat and low-fat beverages have no impact on the LDL size phenotype. Eur J Clin Nutr 59 (2005) 801-804
54. St-Onge M.P., Lamarche B., Mauger J.F., and Jones P.J. Consumption of a functional oil rich in phytosterols and medium-chain triglyceride oil improves plasma lipid profiles in men. J Nutr 133 (2003) 1815-1820
55. Thompson G.R., and Grundy S.M. History and development of plant sterol and stanol esters for cholesterol-lowering purposes. Am J Cardiol 96 suppl 1A (2005) 3D-9D
56. Christiansen L.I., Lahteenmaki P.L., Mannelin M.R., Seppanen-Laakso T.E., Hiltunen R.V., and Yliruusi J.K. Cholesterol-lowering effect of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects. Eur J Nutr 40 (2001) 66-73
57. Mattson F.H., Grundy S.M., and Crouse J.R. Optimizing the effect of plant sterols on cholesterol absorption in man. Am J Clin Nutr 35 (1982) 697-700
58. Volger O.L., van der Boom H., de Wit E.C., van Duyvenvoorde W., Hornstra G., Plat J., et al. Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol 21 (2001) 1046-1052
59. Lees A.M., Mok H.Y., Lees R.S., McCluskey M.A., and Grundy S.M. Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis 28 (1977) 325-338
60. Volpe R., Niittynen L., Korpela R., Sirtori C., Bucci A., Fraone N., et al. Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hypercholesterolaemia. Br J Nutr 86 (2001) 233-239
61. Geelen A., Zock P.L., de Vries J.H., and Katan M.B. Apolipoprotein E polymorphism and serum lipid response to plant sterols in humans. Eur J Clin Invest 32 (2002) 738-742